CoChat

The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes Study

Open access
Davis, Timothy M. E., Jackson, Denise, Davis, Wendy A., Bruce, David G., Chubb, Paul · 2001 · British Journal of Clinical Pharmacology
Cited by 62

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Aims To determine (i) which factors, including metformin, are associated with the fasting plasma lactate concentration in type 2 diabetes, and (ii) whether plasma lactate is associated with haemodynamic and metabolic effects. Methods We measured fasting plasma lactate in 272 well‐characterized diabetic patients from a community‐based sample, 181 (67%) of whom were taking metformin with or without other therapies. Linear regression analysis was used to identify predictors, including metformin therapy, of the plasma lactate, and to investigate associations between plasma lactate and resting pulse rate and serum bicarbonate. Factor analysis assessed independent relationships between groups of cosegregating variables. Results Metformin‐treated patients had higher plasma lactate concentrations than nonmetformin‐treated subjects (geometric mean [s.d. range] 1.86 [1.34–2.59]vs 1.58 [1.09–2.30] mmol l−1, respectively; P < 0.001). In a linear regression model, plasma glucose, BMI and metformin use (but not dose) were independently associated with plasma lactate (P ≤ 0.028); after adjustment for the former two variables, metformin‐treated patients had a mean plasma lactate 0.16 mmol l−1 greater than in subjects not taking the drug. Factor analysis revealed that plasma lactate, plasma glucose, BMI and pulse rate cosegregated but serum bicarbonate was not in this grouping.Conclusions The present results show that metformin therapy increases the fasting plasma lactate in ambulant patients with type 2 diabetes from a community‐based cohort. From associations in the data we hypothesize that this increase reflects (i) increased sympathetic activity in patients with the metabolic syndrome (ii) increased substrate (glucose) availability and (iii) a direct metformin effect.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.0306-5251.2001.01423.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 62

Metadata

Authors
Davis, T. M. E., Jackson, D., Davis, W. A., Bruce, D. G., & Chubb, P.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2001-08
Volume
52
Issue
2
Pages
137-144
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1831814133
Cited by
62
References
5
FWCI
1.04
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes Study. https://app.cochat.ai/papers/10.1046/j.0306-5251.2001.01423.x
The paper
Davis, T. M. E., Jackson, D., Davis, W. A., Bruce, D. G., & Chubb, P. (2001). The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: The Fremantle Diabetes Study. British Journal of Clinical Pharmacology. https://doi.org/10.1046/j.0306-5251.2001.01423.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.